0001209191-18-039658.txt : 20180627
0001209191-18-039658.hdr.sgml : 20180627
20180627161759
ACCESSION NUMBER: 0001209191-18-039658
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180626
FILED AS OF DATE: 20180627
DATE AS OF CHANGE: 20180627
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DRISCOLL FREDERICK W
CENTRAL INDEX KEY: 0001129890
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38327
FILM NUMBER: 18921972
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cue Biopharma, Inc.
CENTRAL INDEX KEY: 0001645460
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473324577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 W. KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-949-2680
MAIL ADDRESS:
STREET 1: 675 W. KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Imagen Biopharma, Inc.
DATE OF NAME CHANGE: 20150617
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-06-26
0
0001645460
Cue Biopharma, Inc.
CUE
0001129890
DRISCOLL FREDERICK W
675 W. KENDALL STREET
CAMBRIDGE
MA
02142
1
0
0
0
Stock Option (right to buy)
12.97
2018-06-26
4
A
0
50000
0.00
A
2025-06-26
Common Stock
50000
50000
D
These Stock Options become exercisable in eight equal semi-annual installments beginning December 26, 2018.
/s/ Frederick Driscoll by Mark Busch, as attorney-in-fact
2018-06-27